"Diabetic friend had trouble finding his preferred formulation outside the U.S." In European countries, there are about 20 formulations available, all well below 10 USD per vial of which 100% is compensated by the obligatory health-insurance. There is no market for marginal improved, extremely overpriced medicine outside of pharma-marketing heavens.